81093-21-2

Basic information

• Product Name: 1-(BROMOMETHYL)-2,3-DIMETHYLBENZENE
• Synonyms: 1-(BROMOMETHYL)-2,3-DIMETHYLBENZENE;2,3-Dimethylbenzyl bromide;Benzene, 1-(bromomethyl)-2,3-dimethyl- (9CI);1-(Bromomethyl)-2,3-dimethylbenzene 95%;2,3-Dimethylbenzyl bromide 95%;1-(Bromomethyl)-2,3-dimethylbenzene, 3-(Bromomethyl)-o-xylene;2,3-Dimethylbenzylbromide95%
• CAS NO: 81093-21-2
• Molecular Formula: C₉H₁₁Br
• Molecular Weight: 199.09
• Product Categories: HALOMETYL;Methyl Halides;Phenyls & Phenyl-Het;Methyl Halides;Phenyls & Phenyl-Het
• Mol File: 81093-21-2.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 240℃
• Flash Point: 105℃
• Appearance: /
• Density: 1.314
• Vapor Pressure: 0.0606mmHg at 25°C
• Refractive Index: 1.554
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 1-(BROMOMETHYL)-2,3-DIMETHYLBENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(BROMOMETHYL)-2,3-DIMETHYLBENZENE(81093-21-2)
• EPA Substance Registry System: 1-(BROMOMETHYL)-2,3-DIMETHYLBENZENE(81093-21-2)

Safety Data

• Statements: 34-36/37/38
• Safety Statements: 26-36/37/39
• RIDADR: 3265
• Hazardous Substances Data: 81093-21-2(Hazardous Substances Data)

Usage

General Description

1-(Bromomethyl)-2,3-dimethylbenzene, also known as α-Bromo-m-xylene, is a chemical compound with the molecular formula C9H11Br. It is a colorless liquid with a strong aromatic odor. This chemical is commonly used as a building block in the synthesis of various pharmaceuticals and organic compounds. It is also used as an intermediate in the production of dyes, pigments, and fragrances. α-Bromo-m-xylene is considered to be a hazardous substance and can cause skin and eye irritation, as well as respiratory and digestive issues if inhaled or ingested. Proper safety precautions and protective equipment should be used when handling this chemical.

InChI:InChI=1/C9H11Br/c1-7-4-3-5-9(6-10)8(7)2/h3-5H,6H2,1-2H3

Upstream product

• 13651-14-4 (2,3-dimethylphenyl)methanol 
• 5779-93-1 2,3-dimethylbenzaldehyde 
• 603-79-2 2,3-dimethylbenzoic acid 

Downstream Products

• 62346-82-1 (2,3-dimethylbenzyl)trimethylsilane 
• 1443541-14-7 4-(4-bromo-1-(2,3-dimethylbenzyl)-2-methyl-1H-benzo[d]imidazol-6-yl)morpholine 
• 1415664-03-7 C₂₄H₂₂N₆S 
• 1351646-48-4 4-[1-(2,3-dimethylbenzyl)-4-methoxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid 
• 1351646-18-8 4-[1-(2,3-dimethylbenzyl)-4-methoxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoate 
• 5779-93-1 2,3-dimethylbenzaldehyde 
• 25173-73-3 3-(2,3-Dimethylphenyl)-propansaeure 
• 128266-36-4 4-<(E)-2-(2,3-Dimethylphenyl)-1-methylethenyl>-1,3-dimethoxy-2-(prop-2-enyl)benzol 

Relevant articles and documents

Total syntheses of multicaulins via oxidative photocyclization of stilbenes

The Wittig reaction of 3-isopropyl-4-methoxybenzaldehyde and 2,3-dimethylbenzylphosphonium bromide afforded the corresponding stilbene mixture 16. Oxidative photocyclization of stilbene 16 with iodine facilitated the first total synthesis of 7-isopropyl-6

Compounds

PCT No. PCT/SE98/00940 Sec. 371 Date Jun. 10, 1998 Sec. 102(e) Date Jun. 10, 1998 PCT Filed May 18, 1998 PCT Pub. No. WO98/54180 PCT Pub. Date Dec. 3, 1998The invention relates to new pharmaceutically active compounds which are P2-purinoceptor 7-transmembrane (TM) G-protein coupled receptor antagonists, compositions containing them and processes for their preparation.